354 related articles for article (PubMed ID: 25331217)
1. Adherence among rural HIV-infected patients in the deep south: a comparison between single-tablet and multi-tablet once-daily regimens.
Tennant SJ; Hester EK; Caulder CR; Lu ZK; Bookstaver PB
J Int Assoc Provid AIDS Care; 2015; 14(1):64-71. PubMed ID: 25331217
[TBL] [Abstract][Full Text] [Related]
2. Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.
Scott Sutton S; Magagnoli J; Hardin JW
Pharmacotherapy; 2016 Apr; 36(4):385-401. PubMed ID: 26923931
[TBL] [Abstract][Full Text] [Related]
3. Comparison of adherence to generic multi-tablet regimens vs. brand multi-tablet and brand single-tablet regimens likely to incorporate generic antiretroviral drugs by breaking or not fixed-dose combinations in HIV-infected patients.
Rwagitinywa J; Lapeyre-Mestre M; Bourrel R; Montastruc JL; Sommet A
Fundam Clin Pharmacol; 2018 Aug; 32(4):450-458. PubMed ID: 29505661
[TBL] [Abstract][Full Text] [Related]
4. Odds of Viral Suppression by Single-Tablet Regimens, Multiple-Tablet Regimens, and Adherence Level in HIV/AIDS Patients Receiving Antiretroviral Therapy.
Sutton SS; Magagnoli J; Hardin JW
Pharmacotherapy; 2017 Feb; 37(2):204-213. PubMed ID: 28028855
[TBL] [Abstract][Full Text] [Related]
5. Real-world adherence and persistence for newly-prescribed HIV treatment: single versus multiple tablet regimen comparison among US medicaid beneficiaries.
Cohen J; Beaubrun A; Bashyal R; Huang A; Li J; Baser O
AIDS Res Ther; 2020 Apr; 17(1):12. PubMed ID: 32238169
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported outcomes in virologically suppressed, HIV-1-Infected subjects after switching to a simplified, single-tablet regimen of efavirenz, emtricitabine, and tenofovir DF.
Hodder SL; Mounzer K; Dejesus E; Ebrahimi R; Grimm K; Esker S; Ecker J; Farajallah A; Flaherty JF;
AIDS Patient Care STDS; 2010 Feb; 24(2):87-96. PubMed ID: 20156091
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety 48 weeks after switching from efavirenz to rilpivirine using emtricitabine/tenofovir disoproxil fumarate-based single-tablet regimens.
Mills AM; Cohen C; Dejesus E; Brinson C; Williams S; Yale KL; Ramanathan S; Wang MH; White K; Chuck SK; Cheng AK
HIV Clin Trials; 2013; 14(5):216-23. PubMed ID: 24144898
[TBL] [Abstract][Full Text] [Related]
8. Comparison of HIV Virologic Failure Rates Between Patients with Variable Adherence to Three Antiretroviral Regimen Types.
Gordon LL; Gharibian D; Chong K; Chun H
AIDS Patient Care STDS; 2015 Jul; 29(7):384-8. PubMed ID: 26114665
[TBL] [Abstract][Full Text] [Related]
9. Single- versus multiple-tablet HIV regimens: adherence and hospitalization risks.
Sutton SS; Hardin JW; Bramley TJ; D'Souza AO; Bennett CL
Am J Manag Care; 2016 Apr; 22(4):242-8. PubMed ID: 27143289
[TBL] [Abstract][Full Text] [Related]
10. Persistence and adherence to single-tablet regimens in HIV treatment: a cohort study from the French National Healthcare Insurance Database.
Raffi F; Yazdanpanah Y; Fagnani F; Laurendeau C; Lafuma A; Gourmelen J
J Antimicrob Chemother; 2015 Jul; 70(7):2121-8. PubMed ID: 25904729
[TBL] [Abstract][Full Text] [Related]
11. Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants.
Palella FJ; Fisher M; Tebas P; Gazzard B; Ruane P; Van Lunzen J; Shamblaw D; Flamm J; Ebrahimi R; Porter D; White K; Hindman J; Elbert E; De-Oertel S; Fralich T
AIDS; 2014 Jan; 28(3):335-44. PubMed ID: 24670520
[TBL] [Abstract][Full Text] [Related]
12. A nucleoside- and ritonavir-sparing regimen containing atazanavir plus raltegravir in antiretroviral treatment-naïve HIV-infected patients: SPARTAN study results.
Kozal MJ; Lupo S; DeJesus E; Molina JM; McDonald C; Raffi F; Benetucci J; Mancini M; Yang R; Wirtz V; Percival L; Zhang J; Zhu L; Arikan D; Farajallah A; Nguyen BY; Leavitt R; McGrath D; Lataillade M; The Spartan Study Team
HIV Clin Trials; 2012; 13(3):119-30. PubMed ID: 22592092
[TBL] [Abstract][Full Text] [Related]
13. Single tablet HIV regimens facilitate virologic suppression and retention in care among treatment naïve patients.
Hemmige V; Flash CA; Carter J; Giordano TP; Zerai T
AIDS Care; 2018 Aug; 30(8):1017-1024. PubMed ID: 29478329
[TBL] [Abstract][Full Text] [Related]
14. Relationship Between Single Tablet Antiretroviral Regimen and Adherence to Antiretroviral and Non-Antiretroviral Medications Among Veterans' Affairs Patients with Human Immunodeficiency Virus.
Yager J; Faragon J; McGuey L; Hoye-Simek A; Hecox Z; Sullivan S; Neubert S; Patel N
AIDS Patient Care STDS; 2017 Sep; 31(9):370-376. PubMed ID: 28771023
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of coformulated efavirenz/emtricitabine/tenofovir single-tablet regimen in treatment-naive patients infected with HIV-1.
Gallien S; Flandre P; Nguyen N; De Castro N; Molina JM; Delaugerre C
J Med Virol; 2015 Feb; 87(2):187-91. PubMed ID: 25070158
[TBL] [Abstract][Full Text] [Related]
16. Adherence after treatment switch from a multiple tablet antiretroviral regimen to a single tablet antiretroviral regimen.
Sutton SS; Magagnoli J; H Cummings T; Hardin JW
Therapie; 2021; 76(6):567-576. PubMed ID: 33589316
[TBL] [Abstract][Full Text] [Related]
17. 96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures.
Johnson M; Grinsztejn B; Rodriguez C; Coco J; DeJesus E; Lazzarin A; Lichtenstein K; Wirtz V; Rightmire A; Odeshoo L; McLaren C
AIDS; 2006 Mar; 20(5):711-8. PubMed ID: 16514301
[TBL] [Abstract][Full Text] [Related]
18. Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting.
Colombo GL; Castagna A; Di Matteo S; Galli L; Bruno G; Poli A; Salpietro S; Carbone A; Lazzarin A
Ther Clin Risk Manag; 2014; 10():9-15. PubMed ID: 24379676
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal tolerability and quality of life in antiretroviral-naive HIV-1-infected patients: data from the CASTLE study.
Malan N; Su J; Mancini M; Yang R; Wirtz V; Absalon J; McGrath D;
AIDS Care; 2010 Jun; 22(6):677-86. PubMed ID: 20467943
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of Single- and Multiple-Tablet Antiretroviral Regimens in Correctional Setting for Treatment-Experienced HIV Patients.
Merker A; Badowski M; Chiampas T; Pérez SE; Patel M; Young J; Werner R
J Correct Health Care; 2018 Jan; 24(1):52-61. PubMed ID: 29239232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
